Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kava extract tested as a natural stress reliever for overworked nurses

NCT ID NCT06177535

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This Mayo Clinic study is testing whether a daily kava supplement can lower stress hormones and reduce burnout in 200 surgical nurses. Participants take either kava extract or a placebo for a set period, and researchers measure changes in cortisol levels and burnout scores. The goal is to see if this natural supplement offers a safe, accessible way to support mental health in demanding healthcare jobs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Kava extract (kavalactones)
What this could lead to
If it works, this could point toward a natural supplement to help manage stress and burnout in high-pressure jobs.
What could go wrong
This is an early-stage study with no phase, so results are uncertain. Kava has known liver safety concerns, and the effect on burnout may be small or no different from placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Surgical services nurses at Mayo Clinic in Rochester, MN. * Able to participate fully in all aspects of the study. * Willing to use birth control for the duration of the study (if of childbearing potential). * Understood and signed study informed consent. Exclusion Criteria: * Pregnant, nursing, or trying to conceive. * Persons with a menstrual cycle who are not willing and able to use an approved contraceptive during the study (female sterilization (tubal ligation, hysterectomy), IUD or another implant, oral or injectable contraceptive, contraceptive patch/ring, diaphragm/cervical cap, male sterilization (vasectomy), male condom, female condom, sponge/spermicide) (Persons who do not have sex with men can participate without the use of an approved contraceptive). * Use of kava or kava-containing products within the past 8 weeks. * Any prior adverse reaction or known sensitivity or allergy to kava or related botanicals (peppers). * Use of acetaminophen that cannot be discontinued or replaced with an NSAID during the study. * Use of oral corticosteroids (e.g., hydrocortisone) or other steroids (e.g., prednisone). * Alcohol use greater than 1 drink per day. * Use of kratom within the past 8 weeks. * Recent history of clinical depression or anxiety diagnosis. * Known significant liver disease or dysfunction. * Known significant kidney disease or dysfunction. * Known Addison's or Cushing's Disease. * Known catecholamine imbalance or medication use which influences catecholamine levels. * History or current diagnosis of cancer (except for successfully treated basal cell carcinoma diagnosed less than 5 years prior to screening or cancer in full remission more than 5 years after diagnosis). * Recent history or acute disease or unstable medical condition. * Surgery planned during the course of the trial. * A known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Minnesota

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.